Resumen

ALCANTARA-HERNANDEZ, Rocío; HERNANDEZ-ESPINOSA, David A.; MEDINA, Luz del C.  y  GARCIA-SAINZ, Jesús A.. G protein-coupled receptors as therapeutic target. Gac. Méd. Méx [online]. 2022, vol.158, n.2, pp.101-107.  Epub 16-Mayo-2022. ISSN 2696-1288.  https://doi.org/10.24875/gmm.21000718.

Receptors are proteins coded by DNA, some of which have already been crystalized, thus allowing the details of their structure at the atomic level and some aspects of their function to be known. This review focuses on the most diverse and abundant family of receptors, G protein-coupled receptors. This family of receptors recognizes and mediates the action of several endogenous ligands (hormones, neurotransmitters, growth factors and local hormones) and also intervenes in the pathogenesis of various diseases, which is why they are targeted by approximately 30 to 40% of medications that are used in daily clinical practice and of various illegal drugs as well. X-ray crystallography is one of the essential tools that has allowed to observe the structure of these receptors in the amino acids that participate in this interaction, which allows to know the binding site of the endogenous ligand and of synthetic molecules that act on them to modulate their action. Molecular modeling or “docking” is also a computational bioinformatics tool that supports research on receptor-ligand binding, which allows the design and development of increasingly specific drugs. These developments have brought along significant changes in fundamental pharmacodynamic concepts.

Palabras llave : G protein-coupled receptors; Biased agonists; G proteins; β-arrestins.